While the contribution of the VEGFR inhibitor SU5416 has been shown to be responsible for inducing lung endothelial cell apoptosis by causing chronic inhibition of VEGFR1 and VEGFR2 RTK, it is insufficient alone to trigger angio-obliterative PAH [3]. This evidence concerns the gene FLT1 and pulmonary arterial hypertension.